Spyre Therapeutics, Inc.
SYRENasdaqCIK 1636282HealthcareFiscal year ends Dec 31
Reports and events: 257 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0921:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-115087 |
| 2026-10-0712:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-065291 |
| 2026-09-0812:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001636282-26-000113 |
| 2026-08-2520:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001636282-26-000105 |
| 2026-08-0420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-26-000098 |
| 2026-08-0420:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001636282-26-000096 |
| 2026-06-2301:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-076961 |
| 2026-06-1512:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001636282-26-000083 |
| 2026-06-0120:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001636282-26-000075 |
| 2026-05-2920:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001636282-26-000056 |
| 2026-05-0512:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-26-000051 |
| 2026-05-0512:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001636282-26-000050 |
| 2026-04-2022:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-045578 |
| 2026-04-1620:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-025508 |
| 2026-04-1320:29 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001628280-26-024906 |
| 2026-04-1311:46 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-024831 |
| 2026-04-1020:01 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001636282-26-000039 |
| 2026-02-1921:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-26-000022 |
| 2026-02-1921:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001636282-26-000020 |
| 2026-01-1214:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009894 |
| 2025-11-0421:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001636282-25-000104 |
| 2025-11-0421:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001636282-25-000102 |
| 2025-10-1721:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-100449 |
| 2025-10-1520:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-240237 |
| 2025-10-1410:19 ET | 8-K | 2.02 Results of operations | 0001193125-25-237904 |
| 2025-08-0520:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-25-000091 |
| 2025-08-0520:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001636282-25-000089 |
| 2025-06-1711:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-141756 |
| 2025-06-0220:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001636282-25-000063 |
| 2025-05-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-25-000050 |
| 2025-05-0820:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001636282-25-000049 |
| 2025-04-1420:33 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001636282-25-000038 |
| 2025-03-0621:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-25-048423 |
| 2025-02-2721:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-25-000022 |
| 2025-02-2721:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001636282-25-000020 |
| 2025-01-1313:08 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-005015 |
| 2024-11-1922:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-048527 |
| 2024-11-1821:09 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-09-30 | 0001636282-24-000113 |
| 2024-11-1821:06 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-06-30 | 0001636282-24-000111 |
| 2024-11-1821:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001636282-24-000109 |
| 2024-11-1821:03 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001636282-24-000107 |
| 2024-11-1821:01 ET | 8-K | 4.02 Non-reliance on financial statements; 8.01 Other events | 0001636282-24-000105 |
| 2024-11-1212:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-046860 |
| 2024-11-0721:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-24-000085 |
| 2024-11-0721:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001636282-24-000083 |
| 2024-10-1510:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-237150 |
| 2024-08-0822:53 ET | 8-K/A | 8.01 Other events | 0001636282-24-000058 |
| 2024-08-0720:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636282-24-000053 |
| 2024-08-0720:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001636282-24-000051 |
| 2024-05-3020:33 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-150395 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.